Second- and third-trimester management of medical termination of pregnancy and fetal death in utero after prior caesarean section

Eur J Obstet Gynecol Reprod Biol. 2011 Aug;157(2):145-9. doi: 10.1016/j.ejogrb.2011.03.013. Epub 2011 Apr 20.

Abstract

Objectives: To evaluate the results and risks of a protocol for second- and third-trimester termination of pregnancy after prior caesarean section.

Study design: This is a retrospective study, conducted in a level 3 (university hospital) maternity unit between January 2001 and September 2008. 67 women with a history of caesarean section underwent second- and third-trimester termination of pregnancy. The protocol was administration of 600 mg mifepristone the first day and application of laminaria tents the second day. One the third day, 48 h after mifepristone, two 200 μg tablets of misoprostol were given orally every 3 h until delivery. Epidural analgesia was performed routinely. Complications analysed were uterine rupture, labour lasting over 12 h, and bleeding requiring blood transfusion.

Results: Delivery was vaginal in 64 cases (95.5%), a median 4 h 20 min (P25: 3 h 5 min, P75: 7 h 7 min) after administration of misoprostol (median number of tablets 2; P25: 2, P75: 4). The median number of tablets of misoprostol was significantly higher for termination of pregnancy than for fetal death in utero (4 vs. 2; p=0.002). The rate of uterine rupture was 4.8% [95% CI: 1.2-14.2]. Bleeding during delivery requiring a transfusion occurred in 2 cases (3.0%; 95% CI: 0.5-11.3).

Conclusion: A high rate of vaginal delivery was achieved at low doses of misoprostol, with a short median induction-to-delivery interval, and a rate of uterine rupture higher than that observed during attempted vaginal delivery at term in a caesarean scar pregnancy. The rate of severe bleeding during delivery was low.

Publication types

  • Evaluation Study

MeSH terms

  • Abortifacient Agents, Nonsteroidal / administration & dosage
  • Abortifacient Agents, Steroidal / administration & dosage
  • Abortion, Induced / methods*
  • Administration, Oral
  • Adult
  • Cesarean Section*
  • Dose-Response Relationship, Drug
  • Female
  • Fetal Death / chemically induced*
  • Humans
  • Mifepristone / administration & dosage*
  • Misoprostol / administration & dosage*
  • Pregnancy
  • Pregnancy Trimester, Second*
  • Pregnancy Trimester, Third*
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Uterine Rupture / epidemiology
  • Uterine Rupture / prevention & control

Substances

  • Abortifacient Agents, Nonsteroidal
  • Abortifacient Agents, Steroidal
  • Misoprostol
  • Mifepristone